Zynex adds David Empey as regulatory compliance expert
This article was originally published in RAJ Devices
Effective 3 January 2011, David Empey becomes director of regulatory compliance for US pain management specialist Zynex1. Mr Empey will focus on helping the firm obtain FDA approvals for its technology as well as additional state and federal licences. Lone Tree, Colorado-based Zynex has two subsidiaries – Zynex Monitoring Solutions and Zynex NeuroDiagnostic – that are currently seeking regulatory approval for products. The firm's third subsidiary, Zynex Medical, has a full range of electrotherapy products already commercially available. Mr Empey has more than 25 years of healthcare-related experience; most recently he was vice-president of operations and compliance for healthcare equipment provider Premier Medical.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals